VALENCIA, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at Cantor Fitzgerald's 2 Annual Healthcare Conference on Tuesday, July 12, 2016 at 3:30 PM (ET) at the Le Parker Meridien in New York.


Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.

Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq and TASE: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. 


Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price:1.17

Change: 0.03 (2.632%)

Volume:2,279,738

Data as of
07/08/2016 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

MannKind Corporation published this content on 08 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 08 July 2016 21:10:06 UTC.

Original documenthttp://investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=978766

Public permalinkhttp://www.publicnow.com/view/6A0971FA9E8D75F184236D6B58B740C53E38696C